Asthma control test (ACT) scores and FeNO correlation

Slides:



Advertisements
Similar presentations
Bronchoprovocation test Presented by: Ashraf Abbas ELMaraghy,MD. Lecturer of Chest Diseases, Ain Shams University.
Advertisements

Bronchial Asthma in the Elderly Presented by: Dr. Naif Shroof FRCP, FACCP, FACP Prof of medicine Jordan University Hospital.
Asthma Update Dr Ed Cetti Consultant Respiratory Physician Spire Gatwick Park Hospital Surrey & Sussex Healthcare NHS Trust.
IPCRG presentations on respiratory diseases Asthma control and severity. What doctors should do to support patients with uncontrolled and severe asthma.
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
A. Nakonechna 1, J. Antipkin 2, T. Umanets 2, V. Lapshyn 2 1) Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
ISEE 2007 PREVALENCE STUDY OF ALLERGY DISEASES IN CHILDREN IN THE CZECH REPUBLIC Růžena Kubínová, Center of Environmental Health, National Institute of.
OBESITY AND ASTHMA Dr. Enrico Heffler MD, Specialist in Allergy and Clinical Immunology Allergy and Clinical Immunology - University.
Clinical Observation of Montelukast as a Partner Agent for Complementary Therapy.
Asthma Diagnosis Prescribing Acute Management Tracey Bradshaw Respiratory Consultant RIE.
NHLBI Childhood Asthma Management Program (CAMP): What Have We Learned? CAMP began as a multicenter (8 clinical + 1 data coordinating center) clinical.
J. Antipkin 1, T. Umanets 1, V. Lapshyn 1, A. Nakonechna 2 1) Institute of Pediatry, Obstetrics and Gynaecology, Kiev, Ukraine 2) Royal Liverpool and Broadgreen.
Asthma What is Asthma ? V1.0 1997 Merck & ..
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
PHARMACODYNAMIC TESTING FOR ORALLY INHALED DRUGS: CORTICOSTEROIDS Staffan Edsbäcker, Assoc.Prof. University of Lund and Experimental Medicine, AstraZeneca,
A STHMA - HOW TO CHOOSE AND INTERPRET LUNG FUNCTION TESTS - A VIEW OF REFERRING PHYSICIAN Matjaž Fležar MD PhD.
Impact of Montelukast on Symptoms of Mild-to-Moderate Persistent Asthma and Exercise-Induced Asthma: The ASTHMA Survey The ASTHMA* survey was supported.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Diagnostic approach to the allergic patient. Allergic conditions in Israel.
Classification and guideline treatment
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Paolo Tassinari MD Instituto de Inmunología
Management of patients with allergic disorders. ASTHMA MANAGEMENT.
The effect of shift work on serial peak expiratory flow measurements used to diagnose occupational asthma Vicky Moore, Maritta Jaakkola, Cedd Burge, Charles.
SGA 2003-W SS Slide 1 Capacity of Oral SINGULAIR to Prevent Asthma Exacerbations CApacidad de SIngulair ™ Oral en la Prevencion de Exacerbaciones.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
Asma na Infância Renato T. Stein, M.D. Pontifícia Universidade Católica Porto Alegre, Brazil.
ASTHMA and the updated GINA Global initiative for asthma 2006 R. Louis Department of Pneumology CHU Sart-Tilman Liege.
Strategies for asthma management VARIABLE ! Prof Huib Kerstjens Groningen Research Institute for Asthma and COPD University Medical Center Groningen.
Acute and chronic management of childhood asthma
Downloaded from – Use of Montelukast for the Treatment of Seasonal (Spring) Allergic Rhinitis.
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Ali …. 65 years old C/O exercise intolerance for 2 years.
ASTHMA & OSAS Fulvio Braido Allergy and Respiratory Diseases Department University of Genoa Ostrutive Sleep Apnea Syndrome (OSAS) and Allergic Respiratory.
Anti-IgE Use in Allergy
1 1 BRONCHIAL ASTHMA Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh Tel: – Fax:
Maggie Harris Independent Respiratory Nurse Specialist
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Lynn Helliwell. Key Facts More than five million people in the UK are being treated for asthma More than five million people in the UK are being.
Asthma in a Nutshell Holger Link, MD. The Complexity of Asthma Immune System Environment Injury and Repair Genes.
Definition of asthma Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory.
Pharmacologic Treatment Of Asthma 1 د. ميريانا البيضة.
Long-term Mortality Among Adults With Asthma A 25-Year Follow-up of 1,075 Outpatients With Asthma Zarqa Ali, MD; Christina Glattre Dirks, MD, PhD; and.
J R Hurst Thorax : Depart. Of Pulmonology R3 백승숙.
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Kaiser G. Lim, MD, FCCP; and Carl Mottram, RRT, RPFT CHEST 2008; 133:1232–124 Jeung Eun.
Sandra D. Anderson and John D. Brannan Department of Respiratory & Sleep Medicine, Royal Prince Alfred Hospital, New South Wales, Australia Current Opinion.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
내과 R2 이지영. INTRODUCTION  Asthma  Allergic airway inflammation,Th2-weighted process  Biomarkers  Phenotypic distinctions  Development of personalized.
Importance of guidelines in the management of Asthma
Increased Exhaled Nitric Oxide and Risk of Loss of Control in Children Undergoing Clinical Asthma Remission   D.V. Chang, J.E. Balinotti, C. Castro Simonelli,
Joyce Hogebrug Specializing in clinical geriatrics Quality of Life and Asthma Control in Elderly Asthmatics: a seven year follow-up – Results from the.
Diagnosing Asthma in Symptomatic children using lung function: Evidence from a Birth Cohort Study Clare Murray1, Philip Foden1, Lesley Lowe1, Hannah Durrington1,
Pulmonary response in sarcoidosis
Asthma-COPD Overlap Syndrome (ACOS) Challenges Diagnosing ACOS
The Asthma COPD Overlap Syndrome
Blood eosinophils as a biomarker in alpha 1 antitrypsin deficiency
Blood eosinophil count and exacerbation risk in patients with COPD
Monitoring asthma in primary care
Evidence-Based Asthma Guidelines
A) Peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) response following once-daily tiotropium Respimat add-on to medium-dose.
The efficacy and safety of omalizumab in pediatric allergic asthma
Asthma- how to choose and interpret lung function tests - a view of referring physician Matjaž Fležar MD PhD.
Effect of omalizumab on change from baseline (B) in a) total asthma symptom score, b) total rhinitis symptom score, and c) combined asthma and rhinitis.
Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation  Anthony P. Sampson, PhDa, Emilio Pizzichini, MD, PhDb,
Management of patients with obesity hypoventilation syndrome (OHS) from diagnosis to integrated care to modify health trajectories. Management of patients.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Presentation transcript:

Asthma control test (ACT) scores and FeNO correlation Yıldırım BZ, Doğan İ, S Serbest, Güven K, Gemicioğlu B.

Aim To evaluate the correlation of ACT and FeNO in asthma control in asthmatics

GINA 2006 and Consept of Control Characteristic Controlled (all of the following) Partly controlled (any measure present in any week Uncontrolled Daytime symptoms None (twice or less/week) More than twice/week Three or more features of partly controlled asthma present in any week Limitation of activities None Any Nocturnal symptoms Need for rescue treatment Lung function (FEV1 or PEF) Normal <80%predicted or personal best Exacerbations One or more/year One in any week

Asthma Control Test (ACT) ACT is a validated, practical instrument to evaluate asthma control ACT measures the quality of asthma control objectively by using simple numerical values as the target of treatment It is reliable, valid and sensitive to fluctuations in asthma control over time

FeNO NO is a noninvasive marker of inflammation It reveals the eosinophilic inflammation and response to corticosteroids in asthmatic patients.

Evaluation of FeNO in Patients Receiving Antiinflamatory Treatment Low Normal Medium High Eosinophilic inflammation Unlikely Present but mild Prominent FeNO ppb <5 5-25 25-50 >50 Consider smoker Symptom+ reconsider diagnosis: Neutrophilic asthma Anxiety Rhinosinusitis GERD Symptom- full compliance Infection Contact with allergen Combine ICS with another drug Increase ICS Do not change the treatment İnsufficient treatment -İncompliance to treatment -technical difficulties -İnsufficient ICS -continous contact with allergens Kharitonov et al., Eur Respir J 2003 21:433-8

Method ACT, pulmonary functions and FeNO were measured in 71 cases who were diagnosed as persistent asthma and were receiving combined therapy

Epidemiological and Functional Characteristics of Our Cases Female/male 48(%67)/23(%33) Mean age 41± 13,5 Smoking history 22 (%28,6) +allergic rhinitis 63 (%88,7) Mean FEV1 2,4±1 lt (%80,7 ±19) Emergency visit 16 (%22,5) Hospitalization 6 (%8,5)

Findings Mean AST score 19 ± 6 Mean FeNO (ppb) 38 ± 38

Mean ACT Scores

Mean FeNO

ACT-FeNO ACT<20 ACT>20 NO<25 ppb 10 (%14) 20 (%28) 23 (%32) 18 (%25)

ACT-FEV1 AKT<20 AKT>20 FEV1>%80 14 (%20) 30 (%42) 9 (%13) 7 (%10) FEV1<%60 2 (%3)

FEV1-FeNO NO<25 ppb NO>25 ppb FEV1>%80 21(%30) 23 (%32) 3 (%4) 13 (%18) FEV1<%60 6 (%8) 5 (%7)

ACT-FeNO ACT scores were found to be negatively correlated with FeNO (by using Pearson correlation test r=-0,342; p=0,004).

ACT-FeNO Correlation

Conclusions ACT and NO are negatively correlated In patients whose ACT scores mean controlled, anti-inflammatory therapy yet may be insufficient. ACT is useful in symptomatic and functional follow-up in asthmatic patients but may not be sufficient in evaluating the inflammation

Conclusions Routine NO measurement combined with ACT may be helpful in adjusting the antiinflammatory treatment in patients who are considered controlled according to ACT only